These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 19577169)

  • 21. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
    Yoo SB; Kim YA; Jeon YK; Kim CW
    Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms.
    Challagundla P; Jorgensen JL; Kanagal-Shamanna R; Gurevich I; Pierson DM; Ferrajoli A; Reyes SR; Medeiros LJ; Miranda RN
    Arch Pathol Lab Med; 2014 Jul; 138(7):903-9. PubMed ID: 24978916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Salient clinical features of lymphoma and related lymphoproliferative disorders].
    Fey MF
    Ther Umsch; 2010 Oct; 67(10):491-5. PubMed ID: 20886453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic alterations in malignant lymphoma].
    Ohno H
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():146-51. PubMed ID: 17474405
    [No Abstract]   [Full Text] [Related]  

  • 25. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement analysis in diagnostic work-up.
    Gazzola A; Sabattini E; Mannu C; Bacci F; Sagramoso Sacchetti CA; Artioli P; Chilli L; Da Pozzo G; Piccioli M; Falini B; Pileri SA; Piccaluga PP
    Pathologica; 2011 Feb; 103(1):14-8. PubMed ID: 21837920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.
    Quintanilla-Martinez L; Sander B; Chan JK; Xerri L; Ott G; Campo E; Swerdlow SH
    Virchows Arch; 2016 Feb; 468(2):141-57. PubMed ID: 26416032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
    Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic CD5+ MALT lymphoma: presentation with Waldenstrom syndrome.
    Mikolaenko I; Listinsky CM
    Ann Diagn Pathol; 2009 Aug; 13(4):272-7. PubMed ID: 19608087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular lymphoma with prominent Dutcher body formation: a pathologic study of 3 cases in comparison with nodal or splenic lymphoplasmacytic lymphoma and marginal zone lymphoma.
    Wang E; Stoecker M; Burchette J; Rehder C
    Hum Pathol; 2012 Nov; 43(11):2001-11. PubMed ID: 22607703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetic analysis of haematological malignancies II: Mature lymphoid neoplasms.
    Bench AJ; Erber WN; Follows GA; Scott MA
    Int J Lab Hematol; 2007 Aug; 29(4):229-60. PubMed ID: 17617076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two for One: B-Cell Lymphomas with Features of Marginal and Follicular Lymphomas.
    Glazyrin A; Patel C; Kujtan L; Madhusudhana S
    Acta Haematol; 2018; 139(2):84-88. PubMed ID: 29408811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells.
    Bu X; Zheng Z; Wang C; Yu Y
    Pathol Res Pract; 2007; 203(3):163-7. PubMed ID: 17307308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FISH detection of t(14;18) in follicular lymphoma on Papanicolaou-stained archival cytology slides.
    Richmond J; Bryant R; Trotman W; Beatty B; Lunde J
    Cancer; 2006 Jun; 108(3):198-204. PubMed ID: 16671111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas.
    Akyurek N; Ren Y; Rassidakis GZ; Schlette EJ; Medeiros LJ
    Cancer; 2006 Oct; 107(8):1844-51. PubMed ID: 16983704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular mantle cell lymphoma with aberrant CD10 expression: a potential diagnostic pitfall.
    Lian DW; Chau YP; Lee LK; Teo C; Yap WM; Chuah KL
    Pathology; 2009; 41(7):704-6. PubMed ID: 20001358
    [No Abstract]   [Full Text] [Related]  

  • 37. Study of the Utility of Myeloid Cell Nuclear Differentiation Antigen (MNDA) in the Diagnosis of Marginal Zone Lymphoma.
    Gupta N; Roychoudry S; Sticco KL; Hsu P; Zhang X; Sheikh-Fayyaz S
    Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):217-223. PubMed ID: 36867739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
    Juárez-Salcedo LM; Castillo JJ
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):639-656. PubMed ID: 31229160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
    Patel N; Durkin L; Bodo J; Hsi ED
    Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Classification and differential diagnosis of B-cell lymphomas].
    Anagnostopoulos I
    Verh Dtsch Ges Pathol; 2003; 87():32-42. PubMed ID: 16888892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.